Prospective study links L. iners dominance and bacterial diversity to cervical lesion severity in dysplasia patients.

This prospective study examined vaginal microbiota composition in 91 patients diagnosed with uterine cervix dysplasia. The analysis focused on bacterial species abundance, diversity, and the presence of specific organisms including Lactobacillus species, Gardnerella vaginalis, and Ureaplasma parvum. No comparator group was utilized, and the study setting was not reported. The primary outcomes assessed included vaginal microbial diversity and cytological abnormalities.

Data analysis revealed that the abundance of vaginal microbes dominated by L. iners increased with the severity of cytologically and histologically confirmed cervical lesions. Additionally, HPV infection was present in 73.1% of samples classified as community state type 3. A statistically significant association was observed regarding the combined presence of G. vaginalis and U. parvum alongside L. iners. Furthermore, bacterial diversity was considerably higher in samples categorized as community state type IV, and an increasing trend in diversity was noted with rising cytological severity of cervical lesions.

Safety data, including adverse events and tolerability, were not reported as this was an observational analysis of biological samples rather than an interventional trial. Key limitations include the nonsignificant difference in bacterial diversity with increasing cytological severity and the lack of reported p-values or confidence intervals for most outcomes. The study suggests potential adverse effects of L. iners and a possible role for bacterial diversity in cervical carcinogenesis, noting an association between L. iners and anaerobic bacteria.

While these observations highlight correlations between specific microbiota profiles and dysplasia severity, the nonsignificant findings for diversity trends limit definitive conclusions. The study does not establish causality, and practice relevance remains uncertain given the absence of reported funding conflicts, follow-up data, or specific clinical guidelines derived from these associations. Clinicians should interpret these results as preliminary observations rather than established diagnostic criteria.